All Posts By

Smartkarma Daily Briefs

Daily Brief Financials: Guoco Group Ltd, UOL Group, Road King Infrastructure, Bank Central Asia, Goldman Sachs Group, Krung Thai Bank Pub, S&P 500 INDEX, THAI CDS USD SR 5Y D14, Russell 2000 Index, Martin Currie Portfolio Invest and more

By | Daily Briefs, Financials

In today’s briefing:

  • Guoco (53 HK): Fourth Time’s A Charm?
  • UOL Group (UOL SP): At Risk of Passive Selling in February
  • Morning Views Asia: Lippo Malls Indonesia Retail Trust, Road King Infrastructure
  • Bank Central Asia (BBCA IJ) – Transacting for a Hybrid Society
  • Goldman Sachs Positioned to Outperform in 2024 with Strong Tailwinds (Part 2)
  • Thai Banks 4Q23 Screener; Stick with Krung Thai, Switch Out of Ayudhya into Kasikorn
  • EQD | SPX WEEKLY Rally Is About to Stop (Temporarily), Then Continue Into April
  • Bond Market Monitor: Thai Bonds Are for Issuers
  • Continue Riding This Bull Market Higher; Small- And Mid-Caps Resuming Uptrends; Downgrading Staples
  • Martin Currie Global Portfolio Trust – High-quality equity offering in an uncertain world


Guoco (53 HK): Fourth Time’s A Charm?

By David Blennerhassett

  • Conglomerate Guoco Group (53 HK) has fielded three privatisation Offers from Guoline (the Quek family) over the past twenty years. 
  • Elliott Advisors, then holding 9.72% of shares out, backed the most recent Offer of HK$135/share in November 2018; but it was voted down at a Scheme Meeting. 
  • Elliott has now, surprisingly, exited. This may open the door for a fourth Offer. Shares popped 14% on the news.  

UOL Group (UOL SP): At Risk of Passive Selling in February

By Brian Freitas

  • UOL Group (UOL SP) has underperformed its Singapore peers and the drop in market cap could result in the stock being deleted from global passive portfolios in February.
  • UOL Group (UOL SP) has traded higher since end October and there has been a steady increase in cumulative excess volume on the stock since then.
  • UOL Group (UOL SP) trades richer than its closest peer, City Developments (CIT SP), on EV/Sales and EV/EBITDA. The recent outperformance presents a trading opportunity.

Morning Views Asia: Lippo Malls Indonesia Retail Trust, Road King Infrastructure

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


Bank Central Asia (BBCA IJ) – Transacting for a Hybrid Society

By Angus Mackintosh

  • Bank Central Asia (BBCA IJ) booked a strong finish to the year with PPOP rising by +15.4% YoY and zero provisioning in 4Q2023, driven by loan growth of +13.9% YoY. 
  • The bank’s net interest income grew by +19.5% YoY, with a stable NIM of 5.5% in 4Q2023 and CASA growth of +4.3% YoY, bringing the CASA ratio to 80.3%.
  • BCA remains a core holding amongst Indonesian banks, with conservative bank guidance of +9%-10% loan growth, stable NIMs and CoC in 2024. Valuations reflect bank returns and quality.

Goldman Sachs Positioned to Outperform in 2024 with Strong Tailwinds (Part 2)

By Pranay Yadav

  • Outlook for interest rates in 2024 remains uncertain with market expectations diverging from Fed’s dot plot. Overall, rate cuts are expected in 2024.
  • Lower rate outlook for 2024 will drive higher deal-making which is likely to benefit Goldman. A slowdown in the US economy could hamper Goldman’s recovery.
  • Market metrics point to a positive sentiment around Goldman Sachs stock amongst analysts with summary analyst recommendation pointing to a Buy rating and average upside of 11%.

Thai Banks 4Q23 Screener; Stick with Krung Thai, Switch Out of Ayudhya into Kasikorn

By Victor Galliano

  • Krung Thai has solid post-provision profitability, close to double digit ROE with a healthy balance sheet, along with attractive PBV and PE ratios
  • We add Kasikorn to the buy list, as its cost of risk sharply improved in 4Q23, suggesting that it peaked in 3Q23; this should improve post-provision returns going forward
  • We remove Ayudhya from the buy list, as its worsening cost of risk trends are eroding post-provision returns; it is also relatively weak in terms of capital adequacy

EQD | SPX WEEKLY Rally Is About to Stop (Temporarily), Then Continue Into April

By Nico Rosti

  • The S&P 500 INDEX is WEEKLY OVERBOUGHT, it may continue higher this week or the next but a pullback is behind the corner.
  • Currently the index has reached beyond the Q3 resistance target (4897) and it’s up 4 weeks in a row.
  • Cover your LONG holdings for the upcoming pullback, going SHORT is also possible but maybe won’t be much profitable as we expect the index main rally to last into April.

Bond Market Monitor: Thai Bonds Are for Issuers

By Warut Promboon

  • Here we are revisiting the Thai bond market, as per requests from our Thai readers, to see the impact of the global rate trajectory on Thailand.
  • The Thai bond market will remain unattractive to foreign institutional investors, in our view.
  • The attempt to increase yield should involve a material change in Thailand’s financial structure and regulatory mindset.

Continue Riding This Bull Market Higher; Small- And Mid-Caps Resuming Uptrends; Downgrading Staples

By Joe Jasper

  • Since early November 2023 we have laid out our bullish expectations for a year-end rally that we anticipated would continue into the early part of 2024. 
  • Here we are in the early part of 2024, and we see every reason to continue riding this bull market higher. We see small- and mid-caps resuming uptrends $IWM $VXF
  • Downgrading Staples (XLP) to underweight after brief stint at market weight. Highlighting several buys within Financials: Property & Casualty Insurance BRK.B, PGR, CB, TRV, ALL, CINF, ERIE, and more

Martin Currie Global Portfolio Trust – High-quality equity offering in an uncertain world

By Edison Investment Research

Martin Currie Global Portfolio Trust’s (MNP’s) manager Zehrid Osmani was correct in his assumption that investors were too conservative in 2023; global equities delivered an above-average total return led by large-cap US technology stocks. However, he believes that the consensus outlook for 2024 is too bullish given economic uncertainty and increasing geopolitical risks. The manager’s view is that with inflation remaining elevated, western central banks will not reduce interest rates until the second half of 2024, which is likely to cause disappointment and stock market volatility. With such an investment backdrop, he stresses the importance of focusing on high-quality companies with structural growth opportunities and strong balance sheets that can weather the prevailing headwinds.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: LianBio, Harrow Health , Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., Cipla Ltd and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • Lianbio -Ads (LIAN) – Tuesday, Oct 31, 2023
  • Harrow Inc (HROW) – Tuesday, Oct 31, 2023
  • Zhangzhou Pientzehuang Pharmaceutical (600436.CH) 2023 Results – Get Ready for More Downside Ahead
  • Cipla (CIPLA IN): Q3FY24 Result- Continued Growth Trajectory Across Key Markets; Positive Outlook


Lianbio -Ads (LIAN) – Tuesday, Oct 31, 2023

By Value Investors Club

Key points (machine generated)

  • LianBio is winding down its portfolio of in-licensed drug candidates and returning cash to shareholders.
  • The company recently sold exclusive rights to develop and commercialize mavacamten in certain areas of Asia to Bristol Myers Squibb for $350 million.
  • LianBio will have approximately $600 million in net cash after the transaction, exceeding its current market capitalization of around $434 million. A strategic review is ongoing, and it is expected that the company will wind down its business and distribute cash to shareholders, potentially leading to a higher share price reflecting its cash holdings.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Harrow Inc (HROW) – Tuesday, Oct 31, 2023

By Value Investors Club

Key points (machine generated)

  • Harrow is a pharmaceutical company specializing in prescription medications for ophthalmologists and optometrists.
  • The company offers FDA-approved branded ophthalmic pharmaceuticals and innovative compounded prescription medicines.
  • Harrow owns commercial rights to ten branded ophthalmic pharmaceutical products and operates ImprimisRx, a pharmaceutical-compounding business.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


Zhangzhou Pientzehuang Pharmaceutical (600436.CH) 2023 Results – Get Ready for More Downside Ahead

By Xinyao (Criss) Wang

  • Pientzehuang’s 2023 results were well below expectations. The performance in 23Q4 was terrible. 2024 performance would continue to be under pressure, without any reversal signals to be seen.
  • In the process of China’s de-financialization, growth potential of assets with strong financial attributes would weaken.Pientzehuang’s ability to raise prices won’t be as strong as rigid-demands such as telecommunications tariffs.
  • Pientzehuang’s stock price performance doesn’t follow traditional TCM companies.It’s not surprising if Pientzehuang’s valuation drops to PE of 15x or even lower. We recommend investors not to rush to bottom-fish.

Cipla (CIPLA IN): Q3FY24 Result- Continued Growth Trajectory Across Key Markets; Positive Outlook

By Tina Banerjee

  • In Q3FY24, Cipla Ltd (CIPLA IN) recorded revenue of INR66B, up 14% YoY, and EBITDA margin of 24.2%, driven by double-digit growth across India, North America, and South Africa.
  • North America business reported highest ever revenue of $230M. India revenue is up 12% YoY, supported by growth across branded prescription, trade generics, and consumer health.
  • EBITDA margin for the full year is trending at a higher end of earlier guidance range of 23–24%. Peptide product launches in the U.S. should strengthen near-term growth prospect.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Alibaba Group Holding , Ola Electric, Avanti Feeds, FirstCry, Koss , TSE Tokyo Price Index TOPIX, O’Reilly Automotive and more

By | Consumer, Daily Briefs

In today’s briefing:

  • Alibaba (9988 HK) 3Q24 Earnings Preview: Could Be Unimpressive, But Just Reorganized Main Business
  • Ola Electric Pre-IPO – The Negatives – Still a Long Road Ahead with Ample Competition
  • Shrimp Industry Shakeup: Ecuador Crisis Sparks Opportunities for Indian Seafood Companies
  • Brainbees Solutions (FirstCry) IPO: The Bear Case
  • Koss Corp (KOSS) – Tuesday, Oct 31, 2023
  • To Raise ROE, Breaking Away from Familiar Relationships and Creating Tension in Management Is Key
  • O’Reilly Automotive Inc (ORLY) – Wednesday, Nov 1, 2023


Alibaba (9988 HK) 3Q24 Earnings Preview: Could Be Unimpressive, But Just Reorganized Main Business

By Ming Lu

  • Alibaba Changed its Tmall Taobao business unit from three centers to six departments.
  • We believe the change means Alibaba is moving its focus from cost cut to revenue growth.
  • We set the stock upside at 26% and the price target at HK$91. Buy.

Ola Electric Pre-IPO – The Negatives – Still a Long Road Ahead with Ample Competition

By Sumeet Singh

  • Ola Electric is looking to raise about US$1bn in its upcoming India IPO.
  • Ola Electric Mobility is a vertically integrated pure EV player in India with manufacturing capabilities for EVs and EV components, including cells.
  • In this note, we talk about the not-so-positive aspects of the deal.

Shrimp Industry Shakeup: Ecuador Crisis Sparks Opportunities for Indian Seafood Companies

By Nimish Maheshwari

  • Ecuador’s crisis, driven by violence and narco-gang threats, impacts the global seafood supply chain, especially the lucrative shrimp exports sector.
  • Resilient amid challenges, India holds its position as the second-largest global shrimp producer, balancing opportunities and persistent challenges in logistics and competition.
  • Investors urged caution in the Indian seafood boom, yet potential opportunities arise from Ecuador’s supply disruptions, with reduced import duty enhancing India’s competitiveness.

Brainbees Solutions (FirstCry) IPO: The Bear Case

By Arun George

  • FirstCry (0172540D IN), India’s largest multi-channel retailing platform for mothers’, babies’ and kids’ products, has filed for a US$700 million IPO. 
  • In Brainbees Solutions (FirstCry) IPO: The Bull Case, we highlighted the key elements of the bull case. In this note, we outline the bear case.
  • The bear case rests on the worrying trend of India’s KPIs, margin pressures, cash burn, and deteriorating balance sheet strength. 

Koss Corp (KOSS) – Tuesday, Oct 31, 2023

By Value Investors Club

Key points (machine generated)

  • The litigation industry is filing lawsuits against companies that manufacture consumer headphones, including major players like Apple, Bose, and Skullcandy.
  • The company in focus has filed lawsuits against several headphone manufacturers and has settled with Apple and Plantronics, earning around $11.0 million in net proceeds.
  • Despite being in a declining industry, the company is currently trading as a net-net and has hidden asset value, suggesting potential upside value of up to 75%, with a downside value only slightly lower than its current levels.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


To Raise ROE, Breaking Away from Familiar Relationships and Creating Tension in Management Is Key

By Aki Matsumoto

  • If the ISS ROE criteria, which seems somewhat slow, were to be resumed, many companies would still be below 5%. However, how many companies are feeling threatened?
  • About 40% of the companies have large shareholders holding more than 20% of their shares, which is one reason why many companies do not feel a sense of threat.
  • Domestic institutional investors should apply the Proxy Voting Guidelines more strictly to companies that do not make maximum efforts to increase their ROE.

O’Reilly Automotive Inc (ORLY) – Wednesday, Nov 1, 2023

By Value Investors Club

Key points (machine generated)

  • O’Reilly Automotive is a retail company specializing in automotive aftermarket parts and services.
  • The company has over 6,000 stores in the US and Mexico, making it one of the largest retailers and suppliers in the industry.
  • O’Reilly Automotive offers both do-it-yourself and professional services for a wide range of domestic and imported automobiles.

This article is sourced from an online content aggregator through publicly available sources and is displayed below for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: To Raise ROE and more

By | Daily Briefs, ESG

In today’s briefing:

  • To Raise ROE, Breaking Away from Familiar Relationships and Creating Tension in Management Is Key


To Raise ROE, Breaking Away from Familiar Relationships and Creating Tension in Management Is Key

By Aki Matsumoto

  • If the ISS ROE criteria, which seems somewhat slow, were to be resumed, many companies would still be below 5%. However, how many companies are feeling threatened?
  • About 40% of the companies have large shareholders holding more than 20% of their shares, which is one reason why many companies do not feel a sense of threat.
  • Domestic institutional investors should apply the Proxy Voting Guidelines more strictly to companies that do not make maximum efforts to increase their ROE.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Zhangzhou Pientzehuang Pharmaceutical (600436.CH) 2023 Results – Get Ready for More Downside Ahead and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Zhangzhou Pientzehuang Pharmaceutical (600436.CH) 2023 Results – Get Ready for More Downside Ahead


Zhangzhou Pientzehuang Pharmaceutical (600436.CH) 2023 Results – Get Ready for More Downside Ahead

By Xinyao (Criss) Wang

  • Pientzehuang’s 2023 results were well below expectations. The performance in 23Q4 was terrible. 2024 performance would continue to be under pressure, without any reversal signals to be seen.
  • In the process of China’s de-financialization, growth potential of assets with strong financial attributes would weaken.Pientzehuang’s ability to raise prices won’t be as strong as rigid-demands such as telecommunications tariffs.
  • Pientzehuang’s stock price performance doesn’t follow traditional TCM companies.It’s not surprising if Pientzehuang’s valuation drops to PE of 15x or even lower. We recommend investors not to rush to bottom-fish.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Benefit One Inc and more

By | Daily Briefs, Most Read

In today’s briefing:

  • Benefit One (2412 JP): Who Will Blink First as M3 Extends the Closing Date?


Benefit One (2412 JP): Who Will Blink First as M3 Extends the Closing Date?

By Arun George

  • Ahead of the 17 January close, M3 Inc (2413 JP) has extended the close of its offer to 15 February due to a request from Benefit One Inc (2412 JP).
  • The merger arb situation has four parties with different priorities – the Board, Pasona Group (2168 JP), Dai Ichi Life Insurance (8750 JP) (with a pre-conditional JPY2,123 offer) and M3.
  • The Board and Pasona want the highest possible price. M3’s inability to table a revised offer suggests that Dai-ichi Life has set the bar too high. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief Australia: Carly Holdings and more

By | Australia, Daily Briefs

In today’s briefing:

  • Carly Holdings Limited – Fleet Growing, Subscriptions Following


Carly Holdings Limited – Fleet Growing, Subscriptions Following

By Research as a Service (RaaS)

  • Carly Holdings Limited (ASX:CL8) operates a vehicle subscription business, which it launched in March 2019, leveraging existing operations, strategic relationships, and technology.
  • Car subscription allows business and retail customers to pay a single monthly fee to access a car for 30 days or more and is an alternative to purchasing or financing a vehicle.
  • Carly has attracted larger automotive industry businesses as shareholders, with a direct offering and services to support automotive manufacturers and dealers to generate revenue from car subscriptions. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thailand: Krung Thai Bank Pub, THAI CDS USD SR 5Y D14 and more

By | Daily Briefs, Thailand

In today’s briefing:

  • Thai Banks 4Q23 Screener; Stick with Krung Thai, Switch Out of Ayudhya into Kasikorn
  • Bond Market Monitor: Thai Bonds Are for Issuers


Thai Banks 4Q23 Screener; Stick with Krung Thai, Switch Out of Ayudhya into Kasikorn

By Victor Galliano

  • Krung Thai has solid post-provision profitability, close to double digit ROE with a healthy balance sheet, along with attractive PBV and PE ratios
  • We add Kasikorn to the buy list, as its cost of risk sharply improved in 4Q23, suggesting that it peaked in 3Q23; this should improve post-provision returns going forward
  • We remove Ayudhya from the buy list, as its worsening cost of risk trends are eroding post-provision returns; it is also relatively weak in terms of capital adequacy

Bond Market Monitor: Thai Bonds Are for Issuers

By Warut Promboon

  • Here we are revisiting the Thai bond market, as per requests from our Thai readers, to see the impact of the global rate trajectory on Thailand.
  • The Thai bond market will remain unattractive to foreign institutional investors, in our view.
  • The attempt to increase yield should involve a material change in Thailand’s financial structure and regulatory mindset.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Sindoh Co Ltd, Samsung C&T, Samsung SDI and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Top 10 Stocks in Korea With Highest Net Cash as Percentage of Market Cap
  • Korean FSC’s Official Disclosure of New Treasury Share Regulations & Potential Trading Dynamics
  • Samsung SDI (006400): No Catalyst in Sight


Top 10 Stocks in Korea With Highest Net Cash as Percentage of Market Cap

By Douglas Kim

  • One of the emerging trends in the Korean equity markets in the past several weeks has been the shift out of high beta, high P/E stocks to deep value stocks.
  • In this insight, we will discuss about the top 10 stocks in Korea with highest net cash as percentage of market cap. 
  • These 10 stocks are up on average 2.9% YTD, outperforming KOSPI which is down 5.9% in the same period.

Korean FSC’s Official Disclosure of New Treasury Share Regulations & Potential Trading Dynamics

By Sanghyun Park

  • Today, the Financial Services Commission of Korea announced treasury stock rule improvements: (1) No new share allocation to treasury shares during equity spinoffs. (2) Strengthened disclosure requirements.
  • No mandatory cancellation may disappoint the market. Nevertheless, the decision not to issue new shares during equity spinoffs amplifies the volume targeted during subsequent tender offers, potentially intensifying price impacts.
  • Also, enhanced disclosure for treasury stocks, especially for companies with over 10% holdings, may trigger significant trading events based on pre-information about holdings and disposals.

Samsung SDI (006400): No Catalyst in Sight

By Henry Soediarko

  • The de facto beneficiary of the EU EV subsidy, and historically, 46% of the sales were generated from Audi and BMW EVs. 
  • Valuation has hit the trough, but with no positive catalyst in sight, it is difficult to make a bull case for Samsung SDI (006400 KS) .
  • If the EU put up higher trade tariff for Chinese EV, it could jolt up SDI’s share price but until then, stay away. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Singapore: UOL Group, Road King Infrastructure and more

By | Daily Briefs, Singapore

In today’s briefing:

  • UOL Group (UOL SP): At Risk of Passive Selling in February
  • Morning Views Asia: Lippo Malls Indonesia Retail Trust, Road King Infrastructure


UOL Group (UOL SP): At Risk of Passive Selling in February

By Brian Freitas

  • UOL Group (UOL SP) has underperformed its Singapore peers and the drop in market cap could result in the stock being deleted from global passive portfolios in February.
  • UOL Group (UOL SP) has traded higher since end October and there has been a steady increase in cumulative excess volume on the stock since then.
  • UOL Group (UOL SP) trades richer than its closest peer, City Developments (CIT SP), on EV/Sales and EV/EBITDA. The recent outperformance presents a trading opportunity.

Morning Views Asia: Lippo Malls Indonesia Retail Trust, Road King Infrastructure

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars